Board governance
Governance, board oversight, and company stewardship.
Cilo Cybin Limited supports corporate governance and the outcomes set out in King IV: an ethical culture, performance and value creation, adequate and effective controls, and trust, good reputation, and legitimacy.
This directors area brings together the board of directors, published committee structures, and governance context in one investor-facing destination so stakeholders can review how oversight is structured across the group.
Use the company structure section on the About page to move directly into each entity board or Holdings sub-committee, and use the governance section for related King IV, empowerment, and transformation information.
Board of directors
Cilo Cybin Holdings
Cilo Cybin Holdings board profiles and committee membership are rendered from the current published investor relations entity record.
Dr Tham Seng Kong
Non-Executive · Board Chairperson
Dr Tham is the Founder and Group Chief Executive Officer of ALPS Global Holding Berhad, a life sciences and biotechnology group focused on advanced genomic, cellular, and precision-medicine platforms. He has built ALPS into an internationally operating, regulated healthcare business with capital-markets exposure, including a US public-market presence via Nasdaq. As Chairman of Cilo Cybin Holdings, he provides strong governance oversight, pharmaceutical perspective, and long-term institutional discipline.
Gabriel Christiaan Theron
Executive
Gabriel is the Founder and Chief Executive Officer of Cilo Cybin Holdings and Cilo Cybin (Pty) Ltd. He founded and built the business into South Africa’s only fully vertically integrated GMP cannabis pharmaceutical platform and one of the largest extraction operations globally, leading it from early licensing through to sustained commercial supply. He has founded and successfully operated multiple businesses and led Cilo Cybin as the first cannabis company listed on the JSE, demonstrating both operational depth and capital-markets readiness.
Henk Vivier
Non-Executive
Hendrik Jacobus "Henk" Vivier is an accomplished entrepreneur with an extensive business track record spanning insurance underwriting, financial services, and regulatory advisory. He has been a founding member and director, since 1996, of Senate Corporate Management (Pty) Ltd, an established insurance underwriting business. Between 1998 and 2000, he was a founding member and CEO of AMLAC (the Alliance of Microlenders and Associated Consumers) and served as a board member of the Micro Finance Regulatory Council (now the National Credit Regulato) and has acted as a regulatory advisor to various listed companies, including PSG and African Bank. Since 2011, Mr Vivier has been founder and CEO of Non Perielle Sweetgrass Farms (Pty) Ltd, an agricultural investment company.
Jessica Moodley-Theron
Executive
Jessica is an Executive Director of Cilo Cybin Holdings and Cilo Cybin Pharmaceutical, overseeing strategic relations, international engagement, and long-term growth initiatives. She is currently Acting CFO/FD for Cilo Cybin Holdings. She brings experience across finance, investment facilitation, and cross-border market development, having worked across the UK, Europe, Southern Africa, and the United States. Her work focuses on positioning the business for sustainable international expansion within highly regulated global markets
Ian McFarlane
Director
Ian is an accomplished pharmaceutical executive with more than 30 years’ commercial leadership experience across the branded, generic, wholesale, and medical cannabis sectors. He has held senior Sales, Marketing, Business Development and Commercial roles within multinational pharmaceutical organisations, building and leading high-performing teams, developing international markets and establishing strategic partnerships across the UK, USA, and EMEA. Most recently, as Director of Strategic Partnerships at IPS Pharma, he has led global strategic and business development within the UK medical cannabis market, working with international producers and brands across market access, licensing, procurement, product development, supply, and commercialisation. Throughout his career, Ian has successfully scaled pharmaceutical businesses, led major product launches, established significant industry partnerships, and managed complex acquisitions and business transformations. He brings to the Group a combination of deep pharmaceutical expertise, international industry relationships, and proven commercial leadership, with a focus on accelerating global growth, strengthening strategic partnerships, and expanding access to pharmaceutical and cannabinoid-based medicines.
Mohd Razef Bin Abdullah
Non-Executive · Social & Ethics Committee Chairperson
Sakekile Baduza
Non-Executive · ARMC Committee Chairperson
Audit, risk, financial reporting, and internal-control oversight.
- Sakekile Baduza ARMC chair
- Henk Vivier
- Mohd Razef Bin Abdullah
Remuneration, nomination, and director reward governance.
- Dr Tham Seng Kong
- Mohd Razef Bin Abdullah
- Sakekile Baduza
Social, ethics, transformation, stakeholder, and sustainability oversight.
- Mohd Razef Bin Abdullah Social & Ethics chair
- Dr Tham Seng Kong
- Henk Vivier
Board of directors
Cilo Cybin (Pty) Ltd
Cilo Cybin (Pty) Ltd board profiles and committee membership are rendered from the current published investor relations entity record.
Dr Tham Seng Kong
Non-Executive · Board Chairperson
Dr Tham is the Founder and Group Chief Executive Officer of ALPS Global Holding Berhad, a life sciences and biotechnology group focused on advanced genomic, cellular, and precision-medicine platforms. He has built ALPS into an internationally operating, regulated healthcare business with capital-markets exposure, including a US public-market presence via Nasdaq. As Chairman of Cilo Cybin Holdings, he provides strong governance oversight, pharmaceutical perspective, and long-term institutional discipline.
Gabriel Christiaan Theron
Executive
Gabriel is the Founder and Chief Executive Officer of Cilo Cybin Holdings and Cilo Cybin (Pty) Ltd. He founded and built the business into South Africa’s only fully vertically integrated GMP cannabis pharmaceutical platform and one of the largest extraction operations globally, leading it from early licensing through to sustained commercial supply. He has founded and successfully operated multiple businesses and led Cilo Cybin as the first cannabis company listed on the JSE, demonstrating both operational depth and capital-markets readiness.
Jessica Moodley-Theron
Executive
Jessica is an Executive Director of Cilo Cybin Holdings and Cilo Cybin Pharmaceutical, overseeing strategic relations, international engagement, and long-term growth initiatives. She is currently Acting CFO/FD for Cilo Cybin Holdings. She brings experience across finance, investment facilitation, and cross-border market development, having worked across the UK, Europe, Southern Africa, and the United States. Her work focuses on positioning the business for sustainable international expansion within highly regulated global markets
Board of directors
The Green Merchant
The Green Merchant board profiles and committee membership are rendered from the current published investor relations entity record.
Gabriel Christiaan Theron
Executive · Board Chairperson
Gabriel is the Founder and Chief Executive Officer of Cilo Cybin Holdings and Cilo Cybin (Pty) Ltd. He founded and built the business into South Africa’s only fully vertically integrated GMP cannabis pharmaceutical platform and one of the largest extraction operations globally, leading it from early licensing through to sustained commercial supply. He has founded and successfully operated multiple businesses and led Cilo Cybin as the first cannabis company listed on the JSE, demonstrating both operational depth and capital-markets readiness.
Jessica Moodley-Theron
Executive
Jessica is an Executive Director of Cilo Cybin Holdings and Cilo Cybin Pharmaceutical, overseeing strategic relations, international engagement, and long-term growth initiatives. She is currently Acting CFO/FD for Cilo Cybin Holdings. She brings experience across finance, investment facilitation, and cross-border market development, having worked across the UK, Europe, Southern Africa, and the United States. Her work focuses on positioning the business for sustainable international expansion within highly regulated global markets
Ian McFarlane
Director
Ian is an accomplished pharmaceutical executive with more than 30 years’ commercial leadership experience across the branded, generic, wholesale, and medical cannabis sectors. He has held senior Sales, Marketing, Business Development and Commercial roles within multinational pharmaceutical organisations, building and leading high-performing teams, developing international markets and establishing strategic partnerships across the UK, USA, and EMEA. Most recently, as Director of Strategic Partnerships at IPS Pharma, he has led global strategic and business development within the UK medical cannabis market, working with international producers and brands across market access, licensing, procurement, product development, supply, and commercialisation. Throughout his career, Ian has successfully scaled pharmaceutical businesses, led major product launches, established significant industry partnerships, and managed complex acquisitions and business transformations. He brings to the Group a combination of deep pharmaceutical expertise, international industry relationships, and proven commercial leadership, with a focus on accelerating global growth, strengthening strategic partnerships, and expanding access to pharmaceutical and cannabinoid-based medicines.
Dr. Tham Seng Kong
Non-Executive
Mr. Brandon Rodney Topham
Non-Executive
Mr. Kovinder Maroothanaden
Non-Executive